Member Info for Scinv_temp

More BS from Burble/Bermuda. Lindy said the issue was in January 2024. The question still remains on what recruitment data did the company estimate that the trial woupd be fully recruited by the end of 2023. The truth is they intentionally mislead us, whether you like it or not.

A whole bunch. About the company presenting at various conferences. Except we don't know what they presented because the last presentation/poster about anything on their website is from November 2023. But they sure have produced many RNSs this year.

Thank you scancell!

Your slave,

Scinv

Nice strawman argument, I didn't say they should update us all the time and individually, did I? All of us means RNS or a video/presentation, but you are obviously very slow so I forgive you.

*that you demonstrate your expertise with?

Bermuda/Burble, any comments or is it stricktly with pumpity pump posts were you demonstrate your "expertise"?

No one complained about how long it takes. The issue is the misleading guidance by the company. Specifically, why did the CEO tell us that with only 16 patients recruited after 2 years (excluding covid period) in September 2023, we would have finished recruitment of 43 by EOY 2023. Do you think the CEO had no idea of the difficulties, has poor deductive logic, or intentionally mislead us because they knew they would ask for cash soon after? Take your pick.

Also, with 27 patients currently recruited, and given the same difficulties that everyone is so superficially eloquent about "reminding", how is the trial going to be complete by Q3/Q4 2024 when we need minimum 3 months for the first readout after the last patient of the 43 has been recruited. Same questions applies as above.

Finally, why did they give an update with only 2 additional patients in November 2023, when the trial had already passed to the second stage (Simon's) with the data we had in September 2023 while it hasn't provided a single update since when surely there is data to report for far more than 2 additional patients? What makes this even worse is that a positive update would have helped with recruitment as well. For example it took us 2 years to get to 16 patients and then 8 months to get to 27 and I think the positive press back then had a positive impact on recruitment. So why not give another update in 2024 to keep the momentum going?

All that superficial talk about the difficulties of trials, genetics of the patients are not incorrect but also do not answer the question why has the company gave such misleading guidance (surely they understand the difficulties as well) when previous recruitment data of the same trial did not support their claims and why has it failed to at least explain themselves and update with proper guidance.

So instead of writting generic and irrelevant to the issue posts here, why don't you email the company to ask them to update ALL of us. I have and they haven't replied. Have you?

Lmao. Maximum delusion. I'm the only one who presented facts in this discussion. But you already know that.

My question is, how? The company has already demonstrated they cannot be trusted to provide proper guidance or even explain why they were so far off.

Not to mention they have data. Why are they not presenting them. They must have data on at least 10 additional patients than the 13 they presented in November. That would have helped to accelerate recruitment as well. So don't you think the company should explain all that instead of you writting misleading nonsense here?

Drivel, designed to mislead the ignorant (again, are you sure you are not the same person as Bermuda) . 1 year delay should be explained by the company.

SCOPE started in August 2019 and in September it was already recruiting. According to study record it was still recruiting April 2020, when covid started to affect clinical trials.

https://classic.clinicaltrials.gov/ct2/history/NCT04079166?A=1&B=2&C=merged#StudyPageTop

But you know what, I'm going to assume that between April 2020 and January 2022 there was no recruitment at al due to covid. So, September 2019 to end of March 2020 that's 6 months and January 2022 to September 2023 when we were informed that 16 patients had been immunised, is 20 months. So let's say roughly 2 years to immunise 16 patients.

So based on what tecruitment data did the CEO expect to recruit 27 patients (43-16) from September 2023 to EOY 2023?

Furthermore, based on what data does the CEO expects the study to finish Q3/Q4 2024? It took us almost 2 years to get to those 16 patients and then another 8 months to immunise another 11 patients (September 2023 16 - May 2024 27). We still need another 16 patients to get to 43 AND minimum 3 months to get the first readout after recruitment. How is the study going to finish by Q4? And given the current recruitment record, how unpredictable is it really?

Correction, recruitment will be completed in Q1 2025 at current rate. So >12 months past original guidance.

So why should the crowd be blindfolded? Didn't the CEO say last September that recruitment will be completed before the end of 2023? Why is the guidance now for one year later*?

Isn't the crowd entitled to an explanation?

*with only 27 patients immunised currently (was 16 in September 2023), it will take until the end of 2024 to complete recruitment of 43.

We are not Scancell's slave minions ffs, we are the ones funding their business and salaries.

Yet I had to ask you to answer to that drivel though it has been going on since this morning. Well played Bermuda.

Hey Bermuda, you saint, how do you feel about raypointers (and several others) position that full results will be presented? Lmao. The truth is Bermuda, you are garden variety intern :)

Is burble the same person as Bermuda? Surely he knows that we need minimum 34 patients for the "full results" and that we only have 27 so far (remember we need 3 months after immunisation fornthe first read-out). In my humble experience it is the pumpity pump people who sell first.

Yawn. Yes. But even if I wasn't there is no rule against non holders posting here.

A thread named after me, here we go again lmao. Keep it up guys. I just hope none of you mortgaged anything to buy shares, like those fools at SNG.

27 patients immunised as of May. Not even the 34 required if ORR remains at 85%. Sadly, this is starting to look a lot like SNG. Sigh.

And on the AACR RNS they said "Previously..." which was even stronger. Bermuda is feeding you balls

🤣🤣🤣